Press Releases ProstaLund AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-06-17 EDT			5-day change	1st Jan Change
0.472 ^SEK	-10.27%		-17.19%	-71.04%

05-31	ProstaLund Secures Order for CoreTherm System in Austria	MT
05-16	ProstaLund AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

New agreement - MR Prof. Dr Karl Diehl starts up with CoreTherm® treatments in Austria	05-31	AQ
ProstaLund AB - Interim report January-March 2024	05-16	AQ
ProstaLund hosted unannounced audit by TÜV SÜD	04-12	AQ
Two new studies with ProstaLund´s Schelin Catheter® presented at EAU24 in Paris	04-08	AQ
Schelin Catheter® - new study confirms efficiency and ease of use	02-27	AQ
Year-end report – ProstaLund AB (publ)	02-16	AQ
New agreement - Esbjerg Hospital starts up with CoreTherm® treatments	12-12	AQ
Interim report - ProstaLund AB (publ)	11-07	AQ
Schelin Catheter® has had its premiere in France.	23-09-11	AQ
Schelin Catheter® beneficial together with TURP	23-09-05	AQ
ProstaLund signs sales agent agreement for France	23-08-31	AQ
Patent has been approved in China	23-08-15	AQ
Very strong sales in the quarter, + 53 %	23-07-14	AQ
ProstaLund decides to withdraw its 510(k) application and intend instead to submit a De Novo application for Schelin Catheter® in the US	23-07-10	AQ
Schelin Catheter® breaking new ground again	23-07-05	AQ
Schelin Catheter® has been approved in Switzerland	23-06-17	AQ
Case report on CoreFlow Soft Stent® published	23-06-01	AQ
First Schelin Catheter®-assisted TURPs performed in Brazil	23-05-22	AQ
22% sales growth in the quarter	23-05-17	AQ
Schelin Catheter® approved in Hainan, China	23-04-25	AQ

No results for this search